Page 23 - Read Online

Page 10 of 12 Kirakli et al. J Cancer Metastasis Treat 2019;5:10 I http://dx.doi.org/10.20517/2394-4722.2018.73

Financial support and sponsorship
None.

Conflicts of interest
All authors declared that there are no conflicts of interest.

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2019.

REFERENCES
1. Barnholtz-Sloan JS, Sloan AE, Davis FG, Vigneau FD, Lai P, et al. Incidence proportions of brain metastases in patients diagnosed (1973 to
2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol 2004;22:2865-72.
2. Schouten LJ, Rutten J, Huveneers HA, Twijnstra A. Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon,
kidney, and lung and melanoma. Cancer 2002;94:2698-705.
3. Zhang I, Zaorsky NG, Palmer JD, Mehra R, Lu B. Targeting brain metastases in ALK-rearranged non-small-cell lung cancer. Lancet Oncol
2015;16:e510-21.
4. Johung KL, Yeh N, Desai NB, Williams TM, Lautenschlaeger T, et al. Extended survival and prognostic factors for patients with ALK-
rearranged non-small-cell lung cancer and brain metastasis. J Clin Oncol 2016;34:123-9.
5. Asher AL, Burri SH, Wiggins WF, Kelly RP, Boltes MO, et al. A new treatment paradigm: neoadjuvant radiosurgery before surgical
resection of brain metastases with analysis of local tumor recurrence. Int J Radiat Oncol Biol Phys 2014;88:899-906.
6. Churilla TM,Weiss SE. Emerging trends in the management of brain metastases from non-small cell lung cancer. Curr Oncol Rep
2018;20:54.
7. Sperduto PW, Kased N, Roberge D, Xu Z, Shanley R, et al. Summary report on the graded prognostic assessment: an accurate and facile
diagnosis-specific tool to estimate survival for patients with brain metastases. J Clin Oncol 2012;30:419-25.
8. American Cancer Society. Cancer Facts and Figures 2016. Atlanta, GA: American Cancer Society; 2016.
9. Sperduto PW, Yang TJ, Beal K, Pan H, Brown PD, et al. The effect of gene alterations and tyrosine kinase inhibition on survival and cause
of death in patients with adenocarcinoma of the lung and brain metastases. Int J Radiat Oncol Biol Phys 2016;96:406-13.
10. Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, et al Recursive partitioning analysis (RPA) of prognostic factors in three Radiation
Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997;37:745-51.
11. Sperduto PW, Chao ST, Sneed PK, Luo X, Suh J, et al. Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients
with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. Int J Radiat Oncol Biol Phys 2010;77:655-61.
12. Sperduto PW, Yang TJ, Beal K, Pan H, Brown PD, et al. Estimating survival in patients with lung cancer and brain metastases: an update of
the graded prognostic assessment for lung cancer using molecular markers (lung-molGPA). JAMA Oncol 2017;3:827-31.
13. Patchell RA, Tibbs PA, Walsh JW, Dempsey RJ, Maruyama Y, et al. A randomized trial of surgery in the treatment of single metastases to
the brain. N Engl J Med 1990;322:494-500.
14. Weinberg JS, Lang FF, Sawaya R. Surgical management of brain metastases. Curr Oncol Rep 2001;3:476-83.
15. Al-Shamy G, Sawaya R. Management of brain metastases: the indispensable role of surgery. J Neurooncol 2009;92:275-82.
16. Kalkanis SN, Kondziolka D, Gaspar LE, Burri SH, Asher AL, et al. The role of surgical resection in the management of newly diagnosed
brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 2010;96:33-43.
17. Andrews DW, Scott CB, Sperduto PW, Flanders AE, Gaspar LE, et al. Whole brain radiation therapy with or without stereotactic
radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet
2004;363:1665-72.
18. Patchell RA, Tibbs PA, Regine WF, Dempsey RJ, Mohiuddin M, et al. Postoperative radiotherapy in the treatment of single metastases to
the brain: a randomized trial. JAMA 1998;280:1485-9.
19. Auchter RM, Lamond JP, Alexander E, Buatti JM, Chappell R, et al. A multiinstitutional outcome and prognostic factor analysis of
radiosurgery for resectable single brain metastasis. Int J Radiat Oncol Biol Phys 1996;35:27-35.
20. Muacevic A, Kreth FW, Horstmann GA, Schmid-Elsaesser R, Wowra B, et al. Surgery and radiotherapy compared with gamma knife
radiosurgery in the treatment of solitary cerebral metastases of small diameter. J Neurosurg 1999;91:35-43.
21. Muacevic A, Wowra B, Siefert A, Tonn JC, Steiger HJ, et al. Microsurgery plus whole brain irradiation versus Gamma Knife surgery alone
for treatment of single metastases to the brain: a randomized controlled multicentre phase III trial. J Neurooncol 2008;87:299-307.
22. Churilla TM CI, Chowdury IH, Handorf E, Collette L, Collette S, et al. Comparison of local control of brain metastasis with
stereotactic radiosurgery versus surgical resection: a secondary analysis of a randomized clinical trial. JAMA Oncol 2018; doi: 10.1001/